|
|
|
Center for Devices and Radiological Health
(CDRH) |
|
|
|
ÄOffice
of in Vitro Diagnostic Device Evaluation and Safety |
|
|
|
ÄArleen
Pinkos |
|
Scientific Reviewer |
|
|
|
|
|
A.
Background |
|
|
|
B. Three
Elements of OTC Review |
|
Accuracy and Reliability |
|
Labeling |
|
Risk vs. Benefit |
|
|
|
C. Conclusion |
|
|
|
|
|
817 OTC products cleared for home use |
|
Diabetic Products |
|
Hormones |
|
Drugs of Abuse |
|
Urine Dipsticks |
|
Fecal Occult Blood |
|
Lipids, PT |
|
|
|
|
|
None cleared or approved |
|
Devices reviewed for OTC- Self diagnosis: |
|
Group A Streptococcus, and Influenza A and B |
|
|
|
|
|
In professional hands: |
|
Sensitivity averaged 55-80%, dependent on
specimen matrix |
|
Specificity averaged 80-90% |
|
|
|
|
|
False negatives – risks are life threatening |
|
False positives – risk of masking serious underlying disease |
|
|
|
|
|
Need to know who, what, when, and why |
|
Special conditions for use that impact
performance |
|
Contraindications |
|
|
|
Drives: |
|
Protocol requirements |
|
Questions raised |
|
Data required |
|
|
|
|
|
|
1. Is
the device accurate and reliable in the hands of lay-users? |
|
|
|
2. Is
the device adequately labeled? |
|
|
|
3. Do benefits
outweigh the risks? |
|
|
|
|
|
|
Is the device accurate and reliable in the hands
of the user? |
|
|
|
Can the test provide the right answer? |
|
Can the lay user get the right answer? |
|
Human Factors (HF) |
|
Risk Mitigation & Safeguards |
|
Stress Studies |
|
|
|
|
|
|
|
Analytical and Clinical Performance |
|
|
|
From initial professional-use submission |
|
|
|
Analytical and Clinical Sensitivity and
Specificity |
|
Accurate (true) result |
|
Quantitative -Bias, total error |
|
Qualitative- Clinical Sensitivity and
Specificity, Predictive Values |
|
|
|
|
|
|
|
|
|
Other Important Parameters |
|
|
|
Cross-reactivity & Interference |
|
|
|
Reproducibility |
|
|
|
Reference intervals |
|
|
|
Environmental factors, stability, reportable
range, calibration, linearity, lot to lot variability, etc. |
|
|
|
|
|
|
|
Consumer Study Goal |
|
Demonstrate comparable performance when used as
intended |
|
|
|
Representative Lay Users |
|
Enrollment criteria, demographics |
|
|
|
“Home” environment |
|
|
|
Evaluate entire test system |
|
Consumers perform all steps, unassisted |
|
Labeling – Representative labeling, or according
to marketing plan. |
|
|
|
|
|
|
|
Clinical or spiked – |
|
Challenging and span expected range |
|
|
|
Prospectively collected if: |
|
establish clinical sensitivity and specificity |
|
demonstrate ability to collect the sample, or |
|
sample is not stable |
|
|
|
Biohazard |
|
|
|
Properly characterized- WHO, CDC, reference
method, or to another device |
|
|
|
|
Comprehensive |
|
|
|
Enough participants and samples |
|
|
|
Correct Statistical Tools |
|
|
|
Masking and randomizing- avoid bias |
|
|
|
Written prior to study |
|
|
|
|
A discipline concerned with how people interact
with the device |
|
|
|
Why are HF so important? |
|
|
|
Users- varying abilities and behaviors |
|
Impact on safety and effectiveness |
|
|
|
|
|
|
|
“Errors” occur when users: |
|
|
|
Fail to perform necessary actions |
|
Add actions |
|
Choose the wrong action |
|
Perform actions poorly |
|
|
|
|
|
|
|
|
“The instructions clearly state that results are
to be read from right to left.” |
|
|
|
“How was I to know they’d read it left to
right?” |
|
|
|
|
|
|
|
|
Effective procedures to address |
|
HF and
other potential problems: |
|
|
|
Hazard Analysis: Identify potential errors and
estimate their risk |
|
Mitigate Risks:
Eliminate or reduce risks to acceptable level |
|
Verify effectiveness of safeguards |
|
|
|
|
|
|
|
Built-in features to detect: |
|
Short sample |
|
Wrong sample |
|
Reagent integrity |
|
|
|
Internal QC- often limited scope |
|
|
|
Lock-out mechanisms? |
|
|
|
Labeling- techniques, but when is it adequate? |
|
|
|
Goal- alert before results are compromised |
|
|
|
|
|
Is External QC |
|
Available and practical? |
|
Adequate? |
|
Needed? |
|
|
|
Will consumers do it ?!! |
|
|
|
|
|
|
|
Need to verify effectiveness of safeguards |
|
|
|
What are stress studies? |
|
|
|
Challenges to the system in order to
characterize performance under various conditions of use |
|
|
|
|
|
|
|
|
|
Artificially simulate potential errors |
|
Concentrate on areas prone to errors or failures |
|
Technique |
|
Follow directions |
|
Deviations in environmental conditions |
|
Observe results |
|
|
|
|
|
|
|
Are the step-by-step instructions simple, concise,
and easy to follow? |
|
7th grade reading level? |
|
|
|
Do consumers know who should use the device and when? |
|
|
|
Clear instructions for interpretation and
follow-up? |
|
Limitations? |
|
Go to a doctor? |
|
What if it didn’t work? |
|
Repeat test? |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Verified-Consumer Study |
|
Value is Limited |
|
“Trial effect” |
|
Will they read it? |
|
|
|
Questionnaire |
|
Completed by consumers after testing |
|
Must be challenging: |
|
Who, what, where, when, how & why? |
|
|
|
|
|
Lay users are unique: |
|
|
|
Unregulated environment |
|
May lack medical and technical training: |
|
evaluate other medical information |
|
collect and transport samples |
|
read and follow directions |
|
May or may not carry out follow-up actions |
|
Highly variable |
|
|
|
|
Risk |
|
|
|
1. What
is the impact of a false-positive or false-negative result on the user
and public health e.g., no
follow-up, adverse medical conditions, unnecessary treatment? |
|
|
|
2. What
are the medical risks to the user and
public health if there is a delay in obtaining a professional
examination and treatment, or if the device gives an equivocal result? |
|
|
|
|
Benefit |
|
|
|
1. What
is the clinical benefit to the patient and public health in terms of screening, diagnosing, or monitoring a
particular disease or condition, or risk factor? |
|
|
|
2. What
are the medical benefits to the patient and public health in having the
test available for home-use as opposed to having the test performed only by
health care professionals? |
|
|
|
|
Is the device accurate and reliable in the hands
of the lay user? |
|
Does the Labeling adequately convey all information necessary to use the device
safely and effectively? |
|
Do benefits outweigh risks? |
|
|
|
If yes, generally found suitable for home-use |
|